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tawﬁkas@hotmaiAbstract This paper reports on development of a system consisting of a portable sequential
injector coupled with potentiometric unit for sensing of chlorpheniramine (CPA), based on the
reaction of CPA with potassium permanganate in acidic media. Various experimental conditions
affecting the potential intensity were studied and incorporated into the procedure. Under the
optimum conditions, linear relationship between the CPA concentration and peak area was
obtained for the concentration range of 0.1–50 ppm. The method reﬂects good recovery with
relative standard deviation (RSD)o3%. The detection limit was 0.05 ppm. The developed method
was successfully applied for determination of CPA in pure form and in pharmaceutical dosage
forms. The results, obtained using the method, are in accord with the results of the British
pharmacopoeia method. In addition to its accuracy and precision, the method has the advantages
of being simple, inexpensive and rapid.
& 2011 Xi’an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Chlorpheniramine, marketed in its salt chlorpheniramine mal-
eate, is a ﬁrst-generation alkyl amine antihistamine drug. It isersity. Production and hosting
n Jiaotong University.
sevier
4277.
l.com, tawﬁk@kfupm.edu.sa.commonly used in pharmaceutical preparations for symptomatic
relief of common cold and allergic diseases. Chlorpheniramine is
one of the most commonly used antihistamines in small-animal
veterinary practice. Chlorpheniramine (Fig. 1) is one of a series
of antihistamines including pheniramine (Naphcon) and its
halogenated derivatives and others including ﬂuorpheniramine,
dexchlorpheniramine, dexbrompheniramine, brompheniramine,
deschlorpheniramine and dipheniramine.
Different methods for the assay of chlorpheniramine mal-
eate in pharmaceutical formulas have been reported in the
literature. An aqueous titration method was proposed invol-
ving the back-titration of excess HCl that is not taken up by
the free base of the drug [1]. In addition, acid-base titrations
were performed potentiometrically with 0.1 M solution of
perchloric acid as titrant [2]. Spectroscopic method was
proposed for the determination of chlorpheniramine maleate
in injection, syrup and tablets [3]. Several other spectroscopic
Sensing of CPA in pharmaceutical applications 247methods have been proposed. The procedure for the determi-
nation of chlorpheniramine maleate and phenylephrine hydro-
chloride in nasal drops has been described [4]. Gas liquid
chromatography was used for separation of antihistamine [5].
Numerous high performance liquid chromatographic methods
have been developed for the determination of chlorophenir-
amine maleate in commercial pharmaceutical preparations
[6 –10]. A micellar electrokinetic chromatographic procedure
has been reported for simultaneous determination of para-
cetamol and chlorpheniramine maleate [11]. Recently, a direct
current polarographic method for the determination of chlor-
pheniramine maleate in pharmaceutical preparations has been
reported [12]. The method was based on the reduction of
chlorpheniramine maleate in an acidic medium (pH 1.2–4.0).
Chlorpheniramine maleate was determined by an electroche-
miluminescent method based on Ru (bpy)32þ immobilized in a
nano-Titania/Naﬁon membrane [13]. Flow injection chemilu-
minescence analysis was reported for chlorpheniramine mal-
eate determination [14]. However, those previous methods
generally either are involved in complicated procedures or
demand many chemicals, which are main drawbacks leading
to contamination problems.
This paper reports on the developing a system of sequential
injector coupled with potentiometer, for sensing and fast
determination of chlorpheniramine. The procedure wasFigure 1 Chemical structure of chlorpheniramine maleate.
Figure 2 Schematic representation of the system used for sensing
PP: peristaltic pump, MV: multiselection valves, S: sample; AC: curre
PC: Readout desktop computer.optimized and its analytical performance was thoroughly
evaluated. The method was successfully applied to the deter-
mination of chlorpheniramine in pharmaceutical formulas.
The method is cost-effective, sensitive and reproducible with a
sampling rate of 18 samples per hour.2. Experimental
2.1. Reagents and chemicals
Potassium permanganate and sulfuric acid were from Fisher
Scientiﬁc Company, Chemical Division, Fair Lawn, New
Jersey 07410, USA. Hydrochloric acid was from BDH
Chemicals Ltd. Poole England. Chlorpheniramine maleate
supplied from Sigma C3025 was used for preparing a standard
solution of 200 ppm. This standard solution and the working
standard solutions were immediately prepared before use.
Chlorpheniramine maleate pharmaceutical forms were kindly
donated by the pharmaceutical industry and used as received.
Water used was deionized distilled water. Tablets samples
were prepared by triturating 20 tablets. The required amount
of the powder was dissolved in water, ﬁltered and diluted to
the required volume.
2.2. Preparation of solutions and real samples
Potassium permanganate 0.1 mol/L solution was prepared by
dissolving 1.5804 g of potassium permanganate in 100 ml
distilled water. After standardization, it was used to prepare
working solutions at the appropriate concentrations.
Sulfuric acid 0.1 mol/L was prepared [15], followed by
dilution process to get the appropriate concentrations.
CPA 1000 ppm was prepared by dissolving the required
amount of chloropheniramine maleate in 100 ml of distilled
water. This stock solution was used to prepare the standard
solutions by appropriate dilution.
The method was applied to the determination of chlorphe-
niramine maleate in drug tablets (Chlorohistol Produced byof chlorpheniramine with; H2SO4: carrier, SP: syringe pump,
nt source, D: electrode detector, DA: digital-to-analog converter,
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U.A.E) and injections. Ten 4-mg-tablets of chlorpheniramine
maleate were ﬁnely powdered. Then, an accurate weighed
powder is taken and stirred at room temperature with enough
amount of water. The resulted solution is ﬁltered. The
injection sample (Allerﬁn 10 mg, Batch No. 551218, The Arab
Pharmaceutical Manufacturing Co. Ltd., Sult-Jordan) was
also used for the analysis.
2.3. Apparatus
The sensing device used in this portable system consists of SIA
combined with a potentiometric cell as a detection unit
(Fig. 2). The system is the FIALab 3500 (Medina, WA
USA). It is composed of a syringe pump, a multi-position
valve, a Z-ﬂow cell with SMA ﬁber optic connectors as well as
pump tubing and PC. The syringe pump is 24,000 steps with
an optical encoder feedback and 1.5 s–20 min per stroke of
2.5 mL size. It is of more than 99% accuracy at full stroke.
The volume capacity of syringe is 2500 mL. The multi-position
valve has eight ports with a standard pressure of 250 psi (gas)/
600 psi (liquid); zero dead volume; chemically inert; port
selection is usually done using the software program [16–18].
The Z-ﬂow cell is 10 mm path length plexiglass compatible
with standard SMA terminated ﬁber optics used. Pump tubing
of 0.30 in. ID Teﬂon type supplied by Upchurch Scientiﬁc,
Inc. (Oak Harbor, WA, USA) was used for connecting the
different units and making both the holding coil (190 cm long)
and the reaction coil (190 cm long).
The potentiometric cell consists of two platinum wires
connected into small holes in the glass cylindrical cell. The
ends of the electrodes are exposed to the solutions that pass
through the cell hole. The other ends of the two electrodes are
connected into the electrical circuit and to the LabJack. The
circuit is used to supply current, and thus the difference in
potential can be recorded. The LabJack can convert the
signals into digital and therefore it can be drawn simply into
the SIA software.
Figure 3 The inﬂuence of ﬂow rate on the peak intensity.
Conditions: CPA concentration 1 ppm; CPA volume 110 mL;
potassium permanganate 0.001 mol/L, 100 mL; current density
10 mA/cm2 ; delay time 20 s; coil length 20 cm.
Figure 4 The inﬂuence of delay time on the peak intensity.
Conditions: CPA concentration 1 ppm; CPA volume 110 mL;
potassium permanganate 0.001 mol/L, 100 mL; current density
10 mA/cm2; ﬂow rate 40 mL/s; coil length 20 cm.3. Results and discussion
3.1. Peaks location
The program for CPA determination was established and well
optimized. The device sequence for one cycle for CPA
determination was performed. Once started, it was noticed
that the response was not stabile because of the difference in
the response of electrodes during passing the solutions.
To achieve a good response, peristaltic pump was used
to continuously carry sulfuric acid solution, used as a
carrier through the syringe pump. This allows for peak base
stability.
3.2. Variables optimization
The variables that were optimized included concentrations and
volumes of potassium permanganate, sulfuric acid and CPA
solutions, ﬂow rate, delay time, applied current and coil length
representing the distance between mixing point and the
electrodes.3.2.1. Concentrations and volumes
The optimum concentration of potassium permanganate was
found to be 0.001 mol/L, and the volume was 100 mL. The
optimum concentration of sulfuric acid was 0.0001 mol/L, and
its volume was 80 mL. The volume of the CPA was 110 mL.
The optimum amounts of the reagents were selected based on
the highest potential.
3.2.2. Flow rates
As shown in Fig. 3, the ﬂow rate was studied in the range
between 30 and 200 mL/s. It was found that the ﬂow rate of
40 mL/s gave the highest and symmetric peak. At this ﬂow
rate, the electrodes gave high response to the difference in
potential. At faster ﬂow rates, there is no enough time of the
electrodes to give proper response to the change in potential.
On the other hand, at lower ﬂow rate, the peak became broad
and asymmetric.
3.2.3. Delay time
The time for the mixing of the reagents is essential in order for
the reaction to take place. The delay time was investigated in
the range between 0 and 50 s. The highest and symmetric peak
Figure 5 The inﬂuence of coil length on the peak intensity.
Conditions: CPA concentration 1 ppm; CPA volume 110 mL;
potassium permanganate 0.001 mol/L, 100 mL; current density
10 mA/cm2; ﬂow rate 40 mL/s; delay time 15 s.
Figure 6 Represents repeated measurements of CPA by the
proposed method. Conditions: CPA concentration 1 ppm; CPA
volume 110 mL; potassium permanganate 0.001 mol/L, 100 mL;
current density 10 mA/cm2; ﬂow rate 40 mL/s; delay time 15 s; coil
length 20 cm.
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Consequently, the delay time of 15 s was chosen for subse-
quent experiments in this work.Figure 7 The signal response to different chlorphenireamine
concentartions; 0.1, 0.5, 1, 5, 10, 20, 30, 40 and 50 ppm. Other
conditions are: CPA volume 110 mL; potassium permanganate
100 mL; current density 10 mA/cm2; delay time 15 s; coil length3.2.4. Coil length
The distance between reagents’ mixing point and the electro-
des was investigated by using tubes of different lengths, 80, 60,
40, 30, 25, 20, 15 and 10 cm. As depicted in Fig. 5, the highest
peak was obtained when 20 cm tube was used. This can be
attributed to the response of the electrodes once the mixture
reaches the electrodes while the reaction takes place at its
optimum. At longer distance, the mixture reaches the electro-
des at the end of its life. At shorter distance, the mixture
reaches the electrodes at the beginning of its life.
20 cm; ﬂow rate 40 mL/s.3.2.5. Current
The applied current was investigated in the range of 1–30 mA/cm2.
The current density of 10 mA/cm2 was found to give the best
symmetric and highest response. The very small amount of current
is found to be essential for electrode polarization and for
electrodes’ regeneration due to its reversibility.3.3. Method evaluation and application
3.3.1. Precision and recovery
The precision was tested with seven injections [19,20]. The
intraday (within day) precision was below 1.2% (Fig. 6). From
these results, it can be concluded that the method has a good
repeatability. The very good interday (between days) precision
from the 1st to the 10th day was 1.6%. From these results, it
can be concluded that the adopted method has a good sense of
reproducibility. Recovery of the procedure was also evaluated
at three concentration levels. The recovery ranged from 97%
to 99%.3.3.2. Sample frequency
On applying the optimum conditions, the proposed method
was used for the determination of CPA. Sampling rate of
about 18 samples per hour was achieved.3.3.3. Calibration curve
The linearity of the method for CPA determination was
studied under the optimum conditions. Fig. 7 presents the
signal response to different CPA concentartions; 0.1, 0.5, 1, 5,
10, 20, 30, 40 and 50 ppm. The applied optimium conditions
were 110 mL of CPA; 100 mL of potassium permanganate;
10 mA/cm2 current density; 15 s delay time; 20 cm coil length
and 40 mL/s ﬂow rate. Linearity of the calibration curve was
obtained in the range of 0.1–50 ppm. When samples with
concentration less than 0.1 ppm were applied, the response was
irreproducible. While at concentrations more than 50 ppm, the
signal was nonlinear. The detection limit was 0.05 ppm with less
than 2% relative error. The correlation coefﬁcient (R2) was 0.998.
3.3.4. Recovery and application
The developed method was applied for the sensing of chlor-
pheniramine maleate in pharmaceutical preparations collected
from drug stores. It is worth mentioning that the excipient
(starch) showed negligible interference with the process. The
mean recovery and the RSD% (relative standard deviation)
are presented in Table 1. The same samples were analyzed
in parallel using the pharmacopoeia standard method
(BP, 2000). Each sample was analyzed in septuplicate using
the both proposed system and BP method. The results
obtained are summarized in Table 1.
Table 1 Results obtained by the proposed system and BP method for the analysis of chlorpheniramine maleate; synthetic sample,
injections and tablets.
Chlorpheniramine sample Recovery by
proposed method (%)
Recovery by
BP (%)
Ofﬁcial
rangea (%)
RSDb (%)
Synthetic sample (1 mg was added) 99 98 98–101 71.1
Allerﬁn 10 mg (injection) 97 96 90–110 71.5
Anallerg 4 mg (tablets) 98 98 92.5–107.5 72.1
aOfﬁcial range of the content of a drug speciﬁed by the British Pharmacopoeia (BP).
bRelative standard deviation of seven measurements.
T.A. Saleh250The results obtained showed acceptable accuracy and
repeatability. The proposed method is cost-effective and has
the advantages of being simple and automated with rapid
analysis. It may be suitable for point of care applications and
quality control laboratories.4. Conclusions
A sensitive portable sequential injection setup for the quanti-
tative sensing of CPA was successfully developed, based on
measuring the difference in potential generated when CPA
reacts with potassium permanganate in acidic media. Under
the optimium conditions, the method is characterized by a low
detection limit, excellent reproducibility and a wide dynamic
range along with sampling frequencies of 18/h. The method
was applied to the analysis of commercially available dosage
forms with no interference. This method is cost-effective, and
therefore suitable for routine pharmaceutical analysis applica-
tion. The method is of sufﬁcient accuracy and precision and
permitted a portable, simple, and time saving assay.
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